Radiographic Findings and Their Temporal Changes in COVID-19 Positive Changes Patients: A Prospective Study

Overview

All Patient irrespective of age with confirmed COVID-19 admitted to hospital and who underwent chest radiograph will be enrolled in the study to find raduigraphic findings and their temporal changes in COVID-19.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: June 30, 2020

Detailed Description

In this prospective trial the investigator will work on radiology findings and their temporal changes in COVID-19 positive patients and who underwent chest radiograph will be enrolled in our study. Patient selection will be consecutive in addition of age , gender and comorbid conditions clinical information will included travel,expose and contact history. All patients should be positive for COVID-19 via laboratory testing with real time reverse transcriptase polymerase chain reaction(rRT-PCR) In addition, the number of rRT-PCR tests performed on each patient, on which test a positive result was found,and the number of days between symptomology onset and date of first positive test will be recorded. In view of the current dynamics, any other reliable diagnostic test(s) if added to the clinical protocol will also be considered for inclusion in this study. Tabulation of radiographic findings for all consecutive X-rays will be done along with the temporal changes of these findings. further, the clinical findings with the outcomes(duration of hospital findings, ventilatory support and discharge/death).

Clinical Trial Outcome Measures

Primary Measures

  • Radiographic findings and their temporal changes in COVID-19 positive patient: A Prospective study
    • Time Frame: 1-2 weeks
    • Determine the radiographic findings in chest X-ray of COVID-19 positive patients.

Secondary Measures

  • Radiographic findings and their temporal changes in COVID-19 positive patient: A Prospective study
    • Time Frame: 4-8 weeks
    • Correlation of clinical findings with the outcomes (duration of hospital stay, ventilatory support, and discharge/death)

Participating in This Clinical Trial

Inclusion Criteria

1.Patients confirmed positive for COVID-19 by rRT-PCR irrespective of age. Exclusion Criteria:

1.Patients with flu like symptoms but negative for COVID-19 by rRT-PCR.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 75 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Max Healthcare Insititute Limited
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Contact(s)
    • Bharat Aggarwal, 9810077484, Bharat.Aggarwal@maxhealthcare.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.